How Antimalarial Drug Resistance Affects Post-Treatment Prophylaxis
Author Information
Author(s): Nicholas J White
Primary Institution: Mahidol-Oxford Research Unit, Faculty of Tropical Medicine, Mahidol University
Hypothesis
Antimalarial drug resistance shortens the duration of post-treatment prophylaxis (PTP).
Conclusion
Antimalarial drug resistance significantly reduces the effectiveness of post-treatment prophylaxis, leading to earlier reinfections.
Supporting Evidence
- Post-treatment prophylaxis (PTP) duration varies with the type of antimalarial drug used.
- Antimalarial drug resistance can lead to earlier reinfections after treatment.
- Immunity plays a role in the effectiveness of post-treatment prophylaxis.
Takeaway
When people get treated for malaria, some medicines can help keep them from getting sick again for a while. But if the malaria germs get used to the medicine, it doesn't work as well, and they can get sick again sooner.
Methodology
The review discusses pharmacokinetic and pharmacodynamic factors affecting post-treatment prophylaxis in relation to antimalarial drug resistance.
Limitations
There are very few data on the duration of PTP following intermittent preventive treatment, and the pharmacokinetic properties of drugs may vary in different populations.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website